Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease

Gastroenterology

Volumn 137, Issue 2, 2009, Pages 532-540

  Mathurin, Philippe ^a,b   Hollebecque, Antoine ^a,b   Arnalsteen, Laurent ^a,b   Buob, David ^a   Leteurtre, Emmanuelle ^a   Caiazzo, Robert ^a,b   Pigeyre, Marie ^a   Verkindt, Hélène ^a   Dharancy, Sébastien ^a,b   Louvet, Alexandre ^a,b   Romon, Monique ^a   Pattou, François ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BALLOON; BARIATRIC SURGERY; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN RESISTANCE; LIVER FIBROSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL;

EID: 67650951419     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.04.052     Document Type: Article

References (56)

1. Adams K.F., Schatzkin A., Harris T.B., et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355 (2006) 763-778
2. Flegal K.M., Graubard B.I., Williamson D.F., and Gail M.H. Excess deaths associated with underweight, overweight, and obesity. JAMA 293 (2005) 1861-1867
3. Fontaine K.R., Redden D.T., Wang C., Westfall A.O., and Allison D.B. Years of life lost due to obesity. JAMA 289 (2003) 187-193
4. McTigue K., Larson J.C., Valoski A., et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 296 (2006) 79-86
5. Teli M.R., Day C.P., Burt A.D., Bennett M.K., and James O.F. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346 (1995) 987-990
6. Wanless I.R., and Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12 (1990) 1106-1110
7. Adams L.A., Sanderson S., Lindor K.D., and Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 42 (2005) 132-138
8. Byron D., and Minuk G.Y. Clinical hepatology: profile of an urban, hospital-based practice. Hepatology 24 (1996) 813-815
9. Daniel S., Ben-Menachem T., Vasudevan G., Ma C.K., and Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 94 (1999) 3010-3014
10. Ludwig J., Viggiano R.T., McGill D.B., and Oh B.J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55 (1980) 434-438
11. Neuschwanter-Tetri B.A., and Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37 (2003) 1202-1219
12. Bacon B.R., Farahvash M.J., Janney C.G., and Neuschwanter-Tetri B.A. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107 (1994) 1103-1109
13. Harrison S.A., Torgerson S., and Hayashi P.H. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 98 (2003) 2042-2047
14. Lee R.G. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 20 (1989) 594-598
15. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., and McCullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116 (1999) 1413-1419
16. Powell E.E., Cooksley W.G.E., Hanson R., Searle J., Halliday J.W., and Powell L.W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11 (1990) 74-80
17. Ratziu V., Giral P., Charlotte F., et al. Liver fibrosis in overweight patients. Gastroenterology 118 (2000) 1117-1123
18. Castera L., Hezode C., Roudot-Thoraval F., et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 52 (2003) 288-292
19. Fartoux L., Chazouilleres O., Wendum D., Poupon R., and Serfaty L. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C. Hepatology 41 (2004) 82-87
20. Browning J.D., and Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114 (2004) 147-152
21. Day C.P., and James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 114 (1998) 842-845
22. Sorensen T.I., Orholm M., Bentsen K.D., Hoybye G., Eghoje K., and Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 2 (1984) 241-244
23. Anty R., Bekri S., Luciani N., et al. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. Am J Gastroenterol 101 (2006) 1824-1833
24. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292 (2004) 1724-1737
25. Maggard M.A., Shugarman L.R., Suttorp M., et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 142 (2005) 547-559
26. O'Brien P.E., Dixon J.B., Brown W., et al. The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg 12 (2002) 652-660
27. Torgerson J.S. The "Swedish Obese Subjects" (SOS) Study. What does weight loss really accomplish?. Fortschr Med 144 (2002) 24-26
28. Angrisani L., Furbetta F., Doldi S.B., et al. Lap Band adjustable gastric banding system: the Italian experience with 1863 patients operated on 6 years. Surg Endosc 17 (2003) 409-412
29. Dixon J.B., O'Brien P.E., Playfair J., et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299 (2008) 316-323
30. Ingelsson E., Sundstrom J., Arnlov J., Zethelius B., and Lind L. Insulin resistance and risk of congestive heart failure. JAMA 294 (2005) 334-341
31. Sjostrom L., Lindroos A.K., Peltonen M., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004) 2683-2893
32. Sjostrom C.D., Lissner L., Wedel H., and Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 7 (1999) 477-484
33. Adams T.D., Gress R.E., Smith S.C., et al. Long-term mortality after gastric bypass surgery. N Engl J Med 357 (2007) 753-761
34. Sjostrom L., Narbro K., Sjostrom C.D., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007) 741-752
35. Castillo J., Fabrega E., Escalante C.F., et al. Liver transplantation in a case of steatohepatitis and subacute hepatic failure after biliopancreatic diversion for morbid obesity. Obes Surg 11 (2001) 640-642
36. Grimm I.S., Schindler W., and Haluszka O. Steatohepatitis and fatal hepatic failure after biliopancreatic diversion. Am J Gastroenterol 87 (1992) 775-779
37. Angulo P. NAFLD, obesity, and bariatric surgery. Gastroenterology 130 (2006) 1848-1852
38. Dixon J.B., Bhatal P.S., and Obrien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121 (2001) 91-100
39. Mathurin P., Gonzalez F., Kerdraon O., et al. The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology 130 (2006) 1617-1624
40. Merriman R.B., Ferrell L.D., Patti M.G., et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 44 (2006) 874-880
41. Eriksson F. Biliointestinal bypass. Int J Obes 5 (1981) 437-447
42. Sjöström L. Surgical intervention as a strategy for treatment of obesity. Endocrine 13 (2000) 213-230
43. Katz A., Nambi S.S., Mather K., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
44. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
45. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwanter-Tetri B.A., and Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
46. Adams L.A., and Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 82 (2006) 315-322
47. Andrade A.R., Cotrim H.P., Alves E., et al. Nonalcoholic fatty liver disease in severely obese individuals: the influence of bariatric surgery. Ann Hepatol 7 (2008) 364-368
48. de Almeida S.R., Rocha P.R., Sanches M.D., et al. Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity. Obes Surg 16 (2006) 270-278
49. Furuya Jr. C.K., de Oliveira C.P., de Mello E.S., et al. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol 22 (2007) 510-514
50. Klein S., Mittendorfer B., Eagon J.C., et al. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology 130 (2006) 1564-1572
51. Liu X., Lazenby A.J., Clements R.H., Jhala N., and Abrams G.A. Resolution of nonalcoholic steatohepatitis after gastric bypass surgery. Obes Surg 17 (2007) 486-492
52. Meinhardt N.G., Souto K.E., Ulbrich-Kulczynski J.M., and Stein A.T. Hepatic outcomes after jejunoileal bypass: is there a publication bias?. Obes Surg 16 (2006) 1171-1178
53. Mummadi R.R., Kasturi K.S., Chennareddygari S., and Sood G.K. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 6 (2008) 1396-1402
54. Ricci G., Bersani G., Rossi A., Pigo F., De Fabritiis G., and Alvisi V. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients. Obes Surg 18 (2008) 1438-1442
55. Anty R., Dahman M., Iannelli A., et al. Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation. Obes Surg 18 (2008) 709-714
56. Dixon J.B., Bhathal P.S., Hughes N.R., and O'Brien P.E. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39 (2004) 1647-1654